Transient silencing of synaptic transmitter release from specific neuronal types by recombinant tetanus toxin light chain fused to antibody variable region.
We developed a novel strategy for conditional silencing of synaptic transmission in specific neuronal types in transgenic animals. We generated a recombinant protein termed immuno-tetanus toxin (ITet), which contains a monoclonal antibody variable region for human interleukin-2 receptor alpha-subunit (IL-2Ralpha) fused to tetanus toxin light chain. ITet was designed to transiently suppress transmitter release from target neurons genetically engineered to express human IL-2Ralpha via proteolytic cleavage of vesicle-associated membrane protein-2 (VAMP-2). The in vivo actions of ITet were investigated by using mutant mice that express IL-2Ralpha in striatal neurons under the control of the gene encoding dopamine D(2) receptor. Unilateral ITet injection into the striatum induced rotational behavior in the mutant mice and the rotations gradually reversed to the normal level. The behavioral alteration was accompanied by a transient decrease in the striatal VAMP-2 level and depolarization-evoked transmitter release in synaptic target region. However, ITet injection caused no structural change in striatal cells and nerve terminals in the mutants. These data indicate that ITet acts on striatal neurons bearing human IL-2Ralpha and temporally reduces their VAMP-2 content, thereby causing the blockade of transmitter release. Our ITet technology provides a useful approach for inducible and reversible control of synaptic transmission in specific neuronal types in the brain.
Kobayashi
Tomoko
T
Department of Molecular Genetics, Institute of Biomedical Sciences, Fukushima Medical University School of Medicine, Fukushima, Japan.
Kai
Nobuyuki
N
Kobayashi
Kenta
K
Fujiwara
Tomonori
T
Akagawa
Kimio
K
Onda
Masanori
M
Kobayashi
Kazuto
K
D000704:Analysis of Variance; D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D003342:Corpus Striatum / Q000166:cytology; D007839:Functional Laterality; D006801:Humans; D053645:Interleukin-2 Receptor alpha Subunit / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D009474:Neurons / Q000187:drug effects*; D018377:Neurotransmitter Agents / Q000378:metabolism*; D011189:Potassium Chloride / Q000494:pharmacology; D017448:Receptors, Dopamine D2 / Q000235:genetics; D011993:Recombinant Fusion Proteins / Q000737:chemistry / Q000494:pharmacology; D013744:Tetanus Toxin / Q000737:chemistry / Q000494:pharmacology*; D013997:Time Factors; D050988:Vesicle-Associated Membrane Protein 2 / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D000906:Antibodies; D053645:Interleukin-2 Receptor alpha Subunit; D018377:Neurotransmitter Agents; D017448:Receptors, Dopamine D2; D011993:Recombinant Fusion Proteins; D013744:Tetanus Toxin; D050988:Vesicle-Associated Membrane Protein 2; D005680:gamma-Aminobutyric Acid; D011189:Potassium Chloride
Trends Neurosci. 1990 Jul;13(7):281-5
1695404
Blood. 1994 Jan 15;83(2):426-34
8286741
J Biol Chem. 1990 Sep 5;265(25):15198-202
2118522
J Immunol. 2006 Dec 15;177(12):8822-34
17142785
J Neurosci. 2003 Oct 8;23(27):9078-88
14534241
Neurosci Res. 2007 Jun;58(2):118-23
17313983
Trends Neurosci. 2005 Jan;28(1):44-50
15626496
Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1132-6
7862648
J Neurosci. 2003 Jul 30;23(17):6759-67
12890769
Science. 2000 Jul 28;289(5479):633-7
10915629
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):13940-5
14615590
Neuron. 2006 Jul 20;51(2):157-70
16846851
Neuron. 2005 Dec 8;48(5):727-35
16337911
Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1352-7
12540832
EMBO J. 1993 Sep;12(9):3365-72
8253064
Clin Cancer Res. 2005 Aug 15;11(16):5840-6
16115924
Trends Neurosci. 1990 Jul;13(7):266-71
1695401
Proc Natl Acad Sci U S A. 2003 May 13;100(10):6169-73
12721372
J Neurosci. 2002 Jul 1;22(13):5287-90
12097479
Brain Res Brain Res Rev. 1995 Jan;20(1):91-127
7711769
Neuroscience. 1980;5(3):461-514
6154905
J Neurosci. 2000 Mar 15;20(6):2418-26
10704516
J Neurosci. 2005 Aug 24;25(34):7743-53
16120775
Neuron. 2007 Apr 19;54(2):205-18
17442243
Cell. 1998 Oct 2;95(1):17-27
9778244
J Biol Chem. 1994 Aug 12;269(32):20213-6
8051110
Neuron. 2004 May 27;42(4):553-66
15157418
Nature. 1989 Jun 1;339(6223):394-7
2498664